NRXS

Neuraxis Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↓ 2/10
  • Momentum↑ 9/10
Neuraxis sales and earnings growth
NRXS Growth
Fair
  • Revenue Y/Y↑ 36.89%
  • EPS Y/Y↓ -163.16%
  • FCF Y/Y↑ 10.43%
Neuraxis gross and profit margin trends
NRXS Profitability
Neutral
  • Gross margin ↑ 84.30%
  • EPS margin↓ -249.00%
  • ROIC↑ 703.70%
Neuraxis net debt vs free cash flow
NRXS Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -157.0

Neuraxis stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗